Pharmaceutical products | Tenderlake

Pharmaceutical products

Contract Value:
-
Notice Type:
Contract Notice
Published Date:
19 March 2019
Closing Date:
24 April 2019
Location(s):
PL213 Miasto Kraków (PL Poland/POLSKA)
Description:

Supply of medicinal products


Dalteparinum natricum

A detailed description in Annex No. 1a to the ToR


Collagen matrix

A detailed description in Annex No. 1a to the ToR


sevoflurane

A detailed description in Annex No. 1a to the ToR


Ondansetron 8 mg

A detailed description in Annex No. 1a to the ToR


Ondansetron 2 mg / ml

A detailed description in Annex No. 1a to the ToR


Alpha interferon

A detailed description in Annex No. 1a to the ToR


denosumab

A detailed description in Annex No. 1a to the ToR


Lipegfilgrastym

A detailed description in Annex No. 1a to the ToR


Fomukal mouthwash

A detailed description in Annex No. 1a to the ToR


Nadroparine and others

A detailed description in Annex No. 1a to the ToR


Closed Instillation System - Contains powder and solvent for suspension for administration into the bladder

A detailed description in Annex No. 1a to the ToR


Infliximab, Alteplase, Thrombin, Heparinum natrium and others

A detailed description in Annex No. 1a to the ToR


Mesnum

A detailed description in Annex No. 1a to the ToR


Caphosol type mouthwash

A detailed description in Annex No. 1a to the ToR


Pamidronic and others

A detailed description in Annex No. 1a to the ToR


Collagen sponge with gentamicin

A detailed description in Annex No. 1a to the ToR


Dexamethasoni natrii phosphas, Lidocainum hydrochloricum and others

A detailed description in Annex No. 1a to the ToR


Darbepoetin alfa

A detailed description in Annex No. 1a to the ToR


filgrastim

A detailed description in Annex No. 1a to the ToR


Contrast agents: Iodixanolum and others

A detailed description in Annex No. 1a to the ToR


Contrast agents - Iopromidum and others

A detailed description in Annex No. 1a to the ToR


Contrast agents - Ioversolum and others

A detailed description in Annex No. 1a to the ToR


Immunoglobulin

A detailed description in Annex No. 1a to the ToR


Contrast agents - Gadoteridolum

A detailed description in Annex No. 1a to the ToR


Rasburicase and others

A detailed description in Annex No. 1a to the ToR


Palonosetron and others

A detailed description in Annex No. 1a to the ToR


desflurane

A detailed description in Annex No. 1a to the ToR


Pegfilgrastimum

A detailed description in Annex No. 1a to the ToR


Mitomycin

A detailed description in Annex No. 1a to the ToR


Furosemidum, Hydrocortison, Sugammadeks, Insulin and others

A detailed description in Annex No. 1a to the ToR


Fentanylum, Oxycodone and others

A detailed description in Annex No. 1a to the ToR


Enoxaparinum

A detailed description in Annex No. 1a to the ToR


Sterile gel for applying the bladder catheter

A detailed description in Annex No. 1a to the ToR


Fludarabini phosphas

A detailed description in Annex No. 1a to the ToR


Amphotericin B, Tigecycline, Caspofungin, Posaconazole, Ceftaroline and others

A detailed description in Annex No. 1a to the ToR

Download full details as .pdf
The Buyer:
Centrum Onkologii Instytut im. Marii Skłodowskiej-Curie Oddział w Krakowie
CPV Code(s):
33600000 - Pharmaceutical products